부산대학교 도서관

교내접속OFF
영문 바로가기
Home
통합검색
학술논문

학술논문

replay검색결과 돌아가기
search검색화면
Corrigendum: Advanced NSCLC patients with EGFR T790M harbouring TP53 R273C or KRAS G12V cannot benefit from osimertinib based on a clinical multicentre study by tissue and liquid biopsy
Document Type
article
Author
Yulong Fu; Anqi Wang; Jieqi Zhou; Wei Feng; Minhua Shi; Xiao Xu; Hongqing Zhao; Liming Cai; Jian Feng; Xuedong Lv; Xiaodong Zhang; Wenjing Xu; Zhengrong Zhang; Guoer Ma; Jian Wang; Tong Zhou; Dahai Zhao; Haohui Fang; Zeyi Liu; Jian-an Huang
Source
Frontiers in Oncology, Vol 13 (2023)
Subject
non-small cell lung cancer
liquid biopsy
gene sequencing
epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)
drug resistance
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Language
English
ISSN
2234-943X

Online Access

Open Access (DOAJ) Open Access (EBSCO) Web of Science JCR 저널정보 Scopus Find it@PNU

메일 발송

이메일

폴더 추가